Display options
Share it on

Sarcoma. 2004;8(1):19-24. doi: 10.1080/13577140410001679211.

Adult pelvic sarcomas: a heterogeneous collection of sarcomas?.

Sarcoma

Claudia M G Keyzer-Dekker, Richard G Houtkamp, Johannes L Peterse, Frits Van Coevorden

Affiliations

  1. Department of Surgery Netherlands Cancer Institute Plesmanlaan 121 Amsterdam 1066 CX The Netherlands.

PMID: 18521389 PMCID: PMC2395600 DOI: 10.1080/13577140410001679211

Abstract

Introduction. Adult pelvic soft tissue sarcomas are a rare group of heterogeneous malignancies. These sarcomas differ from extremity and trunk soft tissue sarcomas in presentation, characteristics and response to treatment.Methods. A retrospective analysis of patient and tumor characteristics, treatment and prognosis and prognostic factors was performed.Results. Between 1977 and 1997, a total of 33 adult patients with soft tissue sarcomas involving the pelvis but excluding uterine leiomyosarcoma were identified. Leiomyosarcomas (18), including six GIST, and rhabdomyosarcomas (eight) were the most commonly seen tumors. At first presentation, nine patients already had metastases. The mean follow-up was 52 months (1-200). Recurrences developed in 15 of the 24 cases (63%) with tumors without metastases at first presentation; in six (25%) recurrence was locally only, in nine distant metastases occurred. The nine patients with metastatic disease at first presentation died of the disease, while eight of the 24 patients with localized disease at presentation died. One patient died of an unrelated cause, four were alive with disease, and 11 patients were alive and free of disease. The only identifiable prognostic factor of disease-free interval and overall survival was histological grade.Conclusion. Soft tissue sarcomas of the pelvis appear to be associated with increased rate of metastasis at the time of diagnosis and higher rates of local recurrence. In this study, multi-modality treatment for most primary tumors did not show a significant benefit in recurrence rate, DFI and OST, when compared to single modality approach. Although the number of patients in this study is small, and different types of sarcomas were studied, the only identifiable predictor for survival was low histological grade of the tumors. The differences of this heterogeneous group of pelvic sarcomas with retroperitoneal, trunk and extremity sarcomas should be taken into consideration in the management of these sarcomas.

References

  1. Eur J Surg Oncol. 1995 Oct;21(5):469-71 - PubMed
  2. J Urol. 1992 Apr;147(4):1032-6; discussion 1036-7 - PubMed
  3. Ann Surg. 1998 Sep;228(3):355-65 - PubMed
  4. Eur J Cancer. 2001 Jun;37(9):1096-103 - PubMed
  5. Cancer. 1994 Feb 1;73(3):637-42 - PubMed
  6. J Urol. 1989 May;141(5):1107-10 - PubMed
  7. Eur J Surg Oncol. 2001 Nov;27(7):662-7 - PubMed
  8. J Surg Oncol. 1994 Jul;56(3):172-7 - PubMed
  9. Cancer. 1996 Feb 15;77(4):675-82 - PubMed
  10. Eur J Surg Oncol. 2001 Sep;27(6):564-8 - PubMed
  11. Eur J Surg Oncol. 1999 Apr;25(2):215-20 - PubMed
  12. Cancer. 1999 Jan 15;85(2):389-95 - PubMed
  13. Surg Oncol Clin N Am. 1997 Oct;6(4):847-62 - PubMed
  14. Eur J Cancer. 1994;30A(10):1459-63 - PubMed
  15. Eur J Surg Oncol. 1994 Aug;20(4):436-40 - PubMed
  16. N Engl J Med. 2002 Aug 15;347(7):472-80 - PubMed

Publication Types